https://glance.eyesoneyecare.com/stories/2025-08-21/jcyte-doses-first-patients-rp-allogeneic-cell-therapy-trial/
jCyte doses first patients in RP allogeneic cell therapy trial
Phase 2b JC02-88 trial to evaluate a single IVT injection of jCell (famzeretcel), an agnostic cell therapy with the potential to restore vision in all RP...
allogeneic cell therapydosesfirstpatientsrp